Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solid acid catalyst process reduces waste and cost for cosmetic UV absorber manufacturing ensuring supply chain stability and high purity specifications.
Patent CN101412677A reveals a green nitration method using WO3/ZrO2 catalyst. This process offers high para-selectivity and reduced waste for reliable supply chains.
Novel metal-free C5 iodination of indoles using NIS or I2. High regioselectivity, mild conditions. Ideal for API intermediates. Cost-effective scale-up.
Novel Lewis acid catalyzed route for Everolimus reduces steps and improves purity. Ideal for pharmaceutical intermediates supply chain cost reduction and scale-up.
Advanced synthesis of 2-chloro-4-(4-chlorophenoxy)-acetophenone via patent CN113816838A. Delivers high purity, optimized solvent recovery, and cost-effective manufacturing for global agrochemical supply chains.
Novel solid acid catalyst method for zoledronic acid. High purity, yield over 85 percent. Reliable pharmaceutical intermediates supplier for cost reduction.
Patent CN110372611A reveals green solvent-free synthesis using heteropolyacid ionic liquids for high-purity quinazolinone intermediates ensuring cost reduction and supply reliability.
Patent CN108129303A reveals high-yield esterification for herbicide intermediates. Achieve superior purity and cost efficiency with scalable green chemistry solutions.
Patent CN113336792B reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonate compounds, offering superior stereoselectivity and scalable manufacturing for NASH therapeutics.
Patent CN109970568B reveals a room-temperature solid acid catalysis route for dimethyl 3-aminophthalate, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Patent CN117947113A reveals dynamic kinetic resolution for high purity chiral intermediates. Enables cost reduction in pharmaceutical manufacturing with scalable enzyme catalysis.
Patent CN112812087A reveals a high-yield 3-step synthesis for Boseine. This method ensures superior purity and cost efficiency for cosmetic active ingredient manufacturing.
Patent CN111072625A reveals a novel diatomite-catalyzed route for 3,4-methylenedioxyacetophenone, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN109912474A enables green synthesis of Z-3-thiocyanatoacrylate. Reduces cost and improves supply chain reliability for high-purity pharma intermediates manufacturing globally.
Patent CN109912474A reveals lactic acid catalyzed route for high-purity pharmaceutical intermediates. Scalable, cost-effective, and environmentally friendly manufacturing process.
Patent CN111484412A reveals a solid acid catalyzed route for high-purity indane diamines, offering significant cost reduction in polyimide manufacturing and enhanced supply chain reliability.
Patent CN103408620B details high yield neohesperidin synthesis. Reduces cost and pollution significantly. Suitable for global food and pharma supply chains demanding quality.
Patent CN102180793B details a high-yield synthesis route for Vitamin E intermediates offering cost reduction and supply chain reliability for global buyers.
Novel acidic ionic liquid catalyst method ensures high purity and recyclable system for pharmaceutical intermediate manufacturing supply chain efficiency.
Patent CN1419557A reveals a novel low-temperature process for fused imidazopyridine derivatives. Discover cost-effective manufacturing and stable crystal forms for API production.